Introduction — The coxib controversies K D Rainsford EditorialNotes 01 September 2005 Pages: 331 - 341
The use of NSAIDs in rheumatic disorders 2005: a global perspective Walter F KeanW Watson Buchanan ReviewPaper 01 September 2005 Pages: 343 - 370
The murky waters of the coxibs: a review of the current state of play Andrew J K OstorBrian L Hazleman ReviewPaper 01 September 2005 Pages: 371 - 380
The murky world of the COX-2-selective agents Ingvar BjarnasonBjarni Thjodleifsson OriginalPaper 01 September 2005 Pages: 381 - 393
COX-2 controversy: where are we and where do we go from here? Dinesh KhannaPuja P KhannaDaniel E Furst OriginalPaper 01 September 2005 Pages: 395 - 402
Coxibs and their aftermath: an (opinionated) commentary, based on some historical viewpoints M Whitehouse OriginalPaper 01 September 2005 Pages: 403 - 417
COX-2 inhibitors: a story of greed, deception and death Georges M Halpern OriginalPaper 01 September 2005 Pages: 419 - 425